Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management

Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple steatosis, through to inflammation and fibrosis with a significant risk for the development of cirrhosis. It is highly prevalent and is associated with significant adverse outcomes both through liver-specific m...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Marjot, T, Moolla, A, Cobbold, J, Hodson, L, Tomlinson, J
Format:	Journal article
Język:	English
Wydane:	Oxford University Press 2019

Podobne zapisy

Non-alcoholic fatty liver disease and diabetes.
od: Hazlehurst, J, i wsp.
Wydane: (2016)

Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital
od: Marjot, T, i wsp.
Wydane: (2017)

Non-alcoholic fatty liver disease
od: Pavlides, M, i wsp.
Wydane: (2019)

Current therapeutic strategies in non-alcoholic fatty liver disease.
od: Dowman, J, i wsp.
Wydane: (2011)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
od: Evgenia Pavlovna Kosobyan, i wsp.
Wydane: (2010-03-01)

Pathogenesis of non-alcoholic fatty liver disease.
od: Dowman, J, i wsp.
Wydane: (2010)

Glucocorticoids and non-alcoholic fatty liver disease.
od: Woods, C, i wsp.
Wydane: (2015)

Novel non-invasive markers, imaging and interventions for the diagnosis, characterisation and treatment of non-alcoholic fatty liver disease
od: Moolla, A
Wydane: (2019)

Non-alcoholic fatty liver disease in common endocrine disorders.
od: Hazlehurst, J, i wsp.
Wydane: (2013)

Non-alcoholic fatty liver disease concerns with glucokinase activators
od: Hodson, L, i wsp.
Wydane: (2018)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
od: Dowman, J, i wsp.
Wydane: (2011)

The diagnosis of non-alcoholic fatty liver disease: authors' reply
od: Dowman, J, i wsp.
Wydane: (2012)

Adopting a Citizen Science Approach in Translational Experimental Medicine Research in Non-Alcoholic Fatty Liver Disease: A Study Protocol
od: Syed Ghulam Sarwar Shah, i wsp.
Wydane: (2023-10-01)

Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome
od: Moolla, A, i wsp.
Wydane: (2020)

Current treatment for non-alcoholic fatty liver disease
od: C. Moctezuma-Velázquez
Wydane: (2018-04-01)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
od: Savic, D, i wsp.
Wydane: (2020)

Non-alcoholic fatty liver disease in women – Current knowledge and emerging conceptsKey points
od: Pei Chia Eng, i wsp.
Wydane: (2023-10-01)

Sodium-glucose cotransporter 2 inhibition does not reduce hepatic steatosis in overweight, insulin-resistant patients without type 2 diabetes
od: Marjot, T, i wsp.
Wydane: (2019)

A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health
od: Moolla, A, i wsp.
Wydane: (2019)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
od: D. V. Blinov
Wydane: (2015-12-01)

Fatty liver disease - non alcoholic to metabolic - A transition of concepts!!
od: Nipun Bawiskar, i wsp.
Wydane: (2024-07-01)

Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey
od: Sheridan, D, i wsp.
Wydane: (2017)

Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population
od: Calanchini, M, i wsp.
Wydane: (2018)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
od: Byeong Geun Song, i wsp.
Wydane: (2023-04-01)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
od: Mehdi Foroughi, i wsp.
Wydane: (2016-01-01)

The Frequency of Non-Alcoholic Fatty Liver Disease in Adults with Diabetes Mellitus
od: Raheel Akhtar Yousafzai, i wsp.
Wydane: (2023-08-01)

Waist-to-height ratio and non-alcoholic fatty liver disease in adults
od: Guotai Sheng, i wsp.
Wydane: (2021-05-01)

Non-Alcoholic Fatty Liver Disease
od: Hui-Hui Tan MRCP(UK), FAMS, i wsp.
Wydane: (2010-03-01)

Non alcoholic fatty liver disease
od: Nahum Méndez-Sánchez
Wydane: (2009-01-01)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
od: Francesca Cainelli, i wsp.
Wydane: (2020-02-01)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
od: Bilon Khambu, i wsp.
Wydane: (2018-09-01)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
od: Ganguli S, i wsp.
Wydane: (2019-11-01)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
od: Pavlides, M, i wsp.
Wydane: (2017)

Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
od: Wensheng Che, i wsp.
Wydane: (2022-11-01)

Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
od: Di Sessa A, i wsp.
Wydane: (2019-08-01)

IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
od: Sebastião Mauro Bezerra DUARTE, i wsp.
Wydane: (2019-11-01)

Shift work and evening chronotype are associated with hepatic fat fraction and non-alcoholic fatty liver disease in 282,303 UK biobank participants
od: Robert Maidstone, i wsp.
Wydane: (2024-01-01)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
od: Brian Ho, i wsp.
Wydane: (2023-12-01)

Of mice and men: is there a future for metformin in the treatment of hepatic steatosis?
od: Green, C, i wsp.
Wydane: (2018)

1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease
od: Anil J. Trindade, i wsp.
Wydane: (2021-08-01)